Improvement exercise tolerance

This study allows improved exercise tolerance in patients undergoing rehabilitation effort

Inclusion Criteria:

• Tumor squamous cell head and neck (excluding nasopharynx) nonmetastatic including cervical lymphadenopathy primitives
• Patient to be treated with curative radiotherapy monofractionnée for at least 6 weeks, with or without concurrent chemotherapy (including targeted therapies)
• KPS ≥ 60

Exclusion Criteria:

• Cancer of the nasopharynx
• Metastatic Patient
• Patients who received neoadjuvant chemotherapy or induction
• Patient parenteral nutrition
• Non-compliant Patient Treatment
• Patient with a cons-indication to the achievement of an effort: clinical signs of pulmonary arterial hypertension (PAH) uncontrolled heart failure, recent myocardial infarction, arrhythmias, unstable angina.
• Patient desaturation in the stress test
• Patient already included in another clinical trial with an experimental molecule
• Pacemaker or defibrillator or neurostimulator
• Contraindications to treatment with standard radiotherapy with or without concurrent chemotherapy